Health services and systems: latest news

Health services and systems resources

Health services and systems features

Health services and systems in your own words

  • Going into hospital

    My experiences of hospitalisation are mixed. I’ve been admitted twice in the last six months, both times for a minor operation. However, following the excellent...

    From: In your own words

Health services and systems news from aidsmap

More news

Health services and systems news selected from other sources

  • United States: A GOP Health Care Plan May Ruin Our Best Chance At Ending HIV And AIDS

    Though it’s unclear how (or if) the ACA will be repealed, the plan passed by the House this month would certainly lead to fewer insured Americans and, by extension, fewer patients able to afford PrEP.

    17 May 2017 | Huffington Post
  • Scott Gottlieb wins confirmation as FDA commissioner

    Dr. Scott Gottlieb is headed back to the Food and Drug Administration. By a vote of 57 to 42, the Senate on Tuesday confirmed Gottlieb, a former FDA deputy commissioner, as the agency’s next chief.

    10 May 2017 | STAT
  • To End AIDS in the United States, Stay True to the National HIV/AIDS Strategy

    Ten years after the strategy effort started, we celebrate our collective progress, but know we are at a precipice. Recent advances will be squandered if Congress and the administration retreat on the ACA and other policy achievements, making it harder for people living with or at risk of HIV to get the services they need to stay alive and healthy.

    09 May 2017 | Project Inform
  • What is at Stake in ACA Repeal and Replace for People with HIV?

    As debate continues surrounding repealing and replacing or transforming aspects of the Affordable Care Act (ACA), and as one such proposal has passed the U.S House of Representatives, questions remain about the potential impact of such changes on high needs populations, including people with HIV. Prior to the ACA, many people with HIV faced significant barriers to accessing health coverage.

    08 May 2017 | Kaiser Family Foundation
  • How pre-existing conditions became front and center in health care vote

    Addressing the contentious issue of pre-existing conditions, and most importantly how to distribute the costs associated with them, is a crucial one for all health care systems. The issue has been with us from the very emergence of health insurance, particularly as for-profit insurers sought to minimize their risks and to maximize their profits. However, while most other industrialized nations have long resolved the issue equitably, the U.S. continues to struggle with it, even after the passage of the ACA.

    05 May 2017 | The Conversation
  • HIV Community Leaders Denounce Passage of American Health Care Act By U.S. House of Representatives

    On Thursday, May 4, the American Health Care Act (AHCA) passed the U.S. House of Representatives in a narrow vote. People living with HIV face distinct risks of life-threatening loss of health care if the AHCA is ultimately signed into law.

    05 May 2017 | The Body
  • EMA and heads of national competent authorities discuss consequences of Brexit

    The European Medicines Agency (EMA) organised an information meeting yesterday with members of its Management Board and heads of the National Competent Authorities (NCAs) of the EU/EEA Member States. The goal was to start discussing how the work related to the evaluation and monitoring of medicines will be shared between Member States in view of the United Kingdom’s (UK) withdrawal from the European Union.

    02 May 2017 | EMA
  • Complexity of health system is 'holding back progress' in HIV care

    While HIV care in England is among the best in the world, the Health and Social Care Act 2012 has created a complex and fragmented system for HIV care. Responsibility for delivering services is spread between NHS England, local NHS organisations and councils, which has made it harder for areas to make co-ordinated changes across HIV services.

    25 April 2017 | The King's Fund
  • Hepatitis drug patent application opposed

    A health advocacy group voiced its opposition Tuesday to a patent application for hepatitis C medicine, Sofosbuvir, filed with the Department of Intellectual Property's Patent Office, which the group said was unjustified. If approved, the drug patent would bar fair competition by precluding the development and distribution of generic versions of Sofosbuvir at lower prices, said a group of 30 activists led by the Aids Access Foundation and Thai Network of People Living with HIV/Aids.

    12 April 2017 | Bangkok Post
  • Ukraine’s Underground AIDS-Treatment Railroad

    For HIV-positive eastern Ukrainians, the struggle against Russian-backed separatists isn't just about dignity – it's about their right to stay alive.

    03 April 2017 | Pulitzer Center
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.